Prof Ferdinando Nicoletti is Member of the Clinical & Scientific Advisory Board of Across Pharmaceuticals. Professor of General Pathology and Immunology, University of Catania (Italy) He serves in the Editorial Boards of multiple international journals including Antioxidants and Redox Signaling, and the European Journal of Pharmacology. Co-founder of GaNiAl Immunotherapeutic Inc. (USA), of Onconox (Copenhagen, Denmark), AURA Biopharm (Oslo, Norway) and Cresence (Oslo, Norway). Successful exit with each company; 20 years of collaboration with pharma.
